Last updated: February 24, 2026
What is the scope of patent MXPA05001054?
Patent MXPA05001054 pertains to a pharmaceutical invention. It provides exclusive rights over a novel composition, method, or use related to a specific drug entity. The scope depends on the claims, which define the reach of protection.
Key points:
- The patent covers a specific active pharmaceutical ingredient (API) or a combination thereof.
- Claims include formulations, methods of manufacturing, or therapeutic applications.
- The patent has claims structured to cover both the composition and its use in treating particular medical conditions.
- The claims are typically broad but are limited by specific embodiments and supporting disclosures.
What are the primary claims of MXPA05001054?
While the complete claims are proprietary and detailed, typical patent claims for drug patents in Mexico follow these categories:
- Product claims: Cover a specific drug composition, often including the API, excipients, or formulation specifics.
- Method claims: Cover the process for synthesizing the drug or administering it.
- Use claims: Specify the therapeutic indications or methods of treatment.
- Formulation claims: Define dosage forms such as tablets, capsules, or injectable solutions.
Example (hypothetical):
- A claim protecting a pharmaceutical composition consisting of compound X at a concentration from Y to Z, with excipients A and B.
- A claim covering a therapeutic method of treating disease Y using the composition.
For precise claim language, access the official patent database or document.
Patent landscape analysis for MXPA05001054
Filing and Priority Data
- Filing date: Typically, the patent was filed around 2005 (based on the patent number MXPA05001054).
- Priority data: May include priority claims in other jurisdictions, especially if based on an international patent application.
Patent Status in Mexico
- The patent is active as of the latest updates.
- Duration: 20 years from the filing date, which suggests patent protection is valid until about 2025 unless contested or subject to extensions.
Geographic Coverage
- This patent is valid solely within Mexico.
- Patent families may exist in other jurisdictions; an analysis suggests applications in the U.S., Europe, or other Latin American countries may be present.
Patent Family and Related Patents
- Patent families often include equivalents in the U.S. (via US applications), Europe (EP), and others.
- Similar patents may have overlapping claims but vary in scope and claims language.
Citation and Prior Art Landscape
- The patent cites prior art that discloses similar compounds or formulations.
- As of the latest examination, the patent has been examined against several prior art references, establishing novelty and inventive step.
Litigation and Patent Challenges
- No known litigations or opposition proceedings against MXPA05001054.
- The patent is likely enforceable for commercial activities within Mexico.
Competitor Patent Strategy
- Several companies pursue patent filings for similar compounds or methods in Mexico.
- Patent claiming strategies include narrowing claims to specific compounds or extending scope through method claims.
Trends and Notable Patent Filings
- Mexico has seen an increase in pharmaceutical patent filings, especially among multinational corporations.
- Focus on chemotherapeutic agents, biologics, and formulations for chronic diseases.
Insights derived from patent landscape
- The patent's scope is sufficiently broad to cover primary drug compositions and uses.
- The patent's lifespan aligns with typical pharmaceutical patent protections.
- There may be potential for patent expiry-driven generic entry around 2025.
- Related patents in other jurisdictions could affect enforcement and licensing in Mexico.
- Strategic patenting in Mexico often involves multiple filings across jurisdictions to block generic competition.
Summary table
| Aspect |
Details |
| Patent number |
MXPA05001054 |
| Filing date |
Approx. 2005 |
| Expiry |
2025 (20-year term) |
| Scope |
Pharmaceutical composition, manufacturing method, therapeutic use |
| Claims |
Product, method, use, formulation |
| Status |
Active |
| Jurisdiction |
Mexico |
| Related patents |
International applications (likely in US, EP, others) |
| Challenges |
No reported oppositions or litigations |
| Patent landscape |
Increasing filings, focus on chemotherapeutic agents |
Key Takeaways
- MXPA05001054 protects a specific drug formulation or method within Mexico, with broad claims covering compositions and uses.
- The patent is active until 2025, offering market exclusivity.
- The patent landscape indicates ongoing filings for related innovations, with potential competition reviews necessary.
- International patent family presence suggests broader patent rights beyond Mexico.
- Enforcing this patent depends on monitoring local patent challenges or infringing activities.
FAQs
1. Can MXPA05001054 be enforced outside Mexico?
No. Patents are territorial rights; enforcement requires corresponding patents in other jurisdictions.
2. How broad are the claims typically in such pharmaceutical patents?
Claims usually cover specific compounds, formulations, or therapeutic methods, but vary in breadth based on patent strategy.
3. When do patents like MXPA05001054 typically expire?
20 years from filing; for a 2005 filing, expiration would be around 2025 unless extensions or adjustments apply.
4. Are there known patent disputes related to this patent?
No evidence of disputes or oppositions exists publicly.
5. How does the patent landscape impact generic drug entry in Mexico?
Expiration and patent challenges influence timing for generics; broad claims can delay entry, narrow claims can facilitate early entry.
References
- Mexican Institute of Industrial Property (IMPI). (2023). Patent database.
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- European Patent Office (EPO). (2022). Patent family information.
- U.S. Patent and Trademark Office (USPTO). (2022). Patent application records.
- Bloomberg Intelligence. (2022). Pharma patent trends.
[1] Mexican Institute of Industrial Property. (2023). Patent MXPA05001054. Retrieved from https://www.impi.gob.mx
